Evolution of understanding of primary bilateral macronodular adrenal hyperplasia

doi:10.16138/j.1673-6087.2023.04.005

Abstract

CLC Number:

R586

ZHOU Weiwei, WANG Weiqing. Evolution of understanding of primary bilateral macronodular adrenal hyperplasia[J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(04): 239-241.

References 21

[1]	Bertherat J, Bourdeau I, Bouys L, et al. Clinical, pathophysiologic, genetic, and therapeutic progress in primary bilateral macronodular adrenal hyperplasia[J]. Endocr Rev, 2023, 44(4): 567-628. doi: 10.1210/endrev/bnac034 URL
[2]	Cavalcante IP, Berthon A, Fragoso MC, et al. Primary bilateral macronodular adrenal hyperplasia: definitely a genetic disease[J]. Nat Rev Endocrinol, 2022, 18(11): 699-711. doi: 10.1038/s41574-022-00718-y pmid: 35922573
[3]	Bouys L, Chiodini I, Arlt W, et al. Update on primary bilateral macronodular adrenal hyperplasia(PBMAH)[J]. Endocrine, 2021, 71(3): 595-603. doi: 10.1007/s12020-021-02645-w
[4]	Vassiliadi DA, Tsagarakis S. Diagnosis and management of primary bilateral macronodular adrenal hyperplasia[J]. Endocr Relat Cancer, 2019, 26(10): R567-R581. doi: 10.1530/ERC-19-0240 URL
[5]	Louiset E, Duparc C, Young J, et al. Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia[J]. N Engl J Med, 2013, 369(22): 2115-2125. doi: 10.1056/NEJMoa1215245 URL
[6]	Assié G, Libé R, Espiard S, et al. ARMC5 mutations in macronodular adrenal hyperplasia with Cushing’s syndrome[J]. N Engl J Med, 2013, 369(22): 2105-2114. doi: 10.1056/NEJMoa1304603 URL
[7]	Gagliardi L, Schreiber AW, Hahn CN, et al. ARMC5 mutations are common in familial bilateral macronodular adrenal hyperplasia[J]. J Clin Endocrinol Metab, 2014, 99(9): E1784-E1792. doi: 10.1210/jc.2014-1265 URL
[8]	Faucz FR, Zilbermint M, Lodish MB, et al. Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation[J]. J Clin Endocrinol Metab, 2014, 99(6): E1113-E1119. doi: 10.1210/jc.2013-4280 URL
[9]	Espiard S, Drougat L, Libé R, et al. ARMC5 mutations in a large cohort of primary macronodular adrenal hyperplasia: clinical and functional consequences[J]. J Clin Endocrinol Metab, 2015, 100(6): E926-E935. doi: 10.1210/jc.2014-4204 URL
[10]	Elbelt U, Trovato A, Kloth M, et al. Molecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma[J]. J Clin Endocrinol Metab, 2015, 100(1): E119-E128. doi: 10.1210/jc.2014-2648 URL
[11]	Chasseloup F, Bourdeau I, Tabarin A, et al. Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing’s syndrome: a multicentre, retrospective, cohort study[J]. Lancet Diabetes Endocrinol, 2021, 9(12): 813-824. doi: 10.1016/S2213-8587(21)00236-9 URL
[12]	Vaczlavik A, Bouys L, Violon F, et al. KDM1A inactivation causes hereditary food-dependent Cushing syndrome[J]. Genet Med, 2022, 24(2): 374-383. doi: 10.1016/j.gim.2021.09.018 URL
[13]	Violon F, Bouys L, Berthon A, et al. Impact of morphology in the genotype and phenotype correlation of bilateral macronodular adrenocortical disease(BMAD)[J]. Endocr Pathol, 2023, 34(2): 179-199. doi: 10.1007/s12022-023-09751-7
[14]	Lacroix A. Extensive expertise in endocrinology: glucose-dependent insulinotropic peptide-dependent Cushing’s syndrome[J]. Eur J Endocrinol, 2023, 188(3): R56-R72. doi: 10.1093/ejendo/lvad026 pmid: 36857084
[15]	Meloche-Dumas L, Mercier F, Lacroix A. Role of unilateral adrenalectomy in bilateral adrenal hyperplasias with Cushing’s syndrome[J]. Best Pract Res Clin Endocrinol Metab, 2021, 35(2): 101486. doi: 10.1016/j.beem.2021.101486 URL
[16]	Rubinstein G, Osswald A, Braun LT, et al. The role of adrenal venous sampling(AVS) in primary bilateral macronodular adrenocortical hyperplasia (PBMAH): a study of 16 patients[J]. Endocrine, 2022, 76(2): 434-445. doi: 10.1007/s12020-022-03020-z pmid: 35274284
[17]	Zhang R, Rubinstein G, Vetrivel S, et al. Steroid profiling using liquid chromatography mass spectrometry during adrenal vein sampling in patients with primary bilateral macronodular adrenocortical hyperplasia[J]. Front Endocrinol (Lausanne), 2022, 13: 1079508. doi: 10.3389/fendo.2022.1079508 URL
[18]	Debillon E, Velayoudom-Cephise FL, Salenave S, et al. Unilateral adrenalectomy as a first-line treatment of Cushing’s syndrome in patients with primary bilateral macronodular adrenal hyperplasia[J]. J Clin Endocrinol Metab, 2015, 100(12): 4417-4424. doi: 10.1210/jc.2015-2662 URL
[19]	Osswald A, Quinkler M, Di Dalmazi G, et al. Long-term outcome of primary bilateral macronodular adrenocortical hyperplasia after unilateral adrenalectomy[J]. J Clin Endocrinol Metab, 2019, 104(7): 2985-2993. doi: 10.1210/jc.2018-02204 pmid: 30844071
[20]	Lacroix A, Tremblay J, Rousseau G, et al. Propranolol therapy for ectopic beta-adrenergic receptors in adrenal Cushing’s syndrome[J]. N Engl J Med, 1997, 337(20): 1429-1434. doi: 10.1056/NEJM199711133372004 URL
[21]	St-Jean M, Bourdeau I, Martin M, et al. Aldosterone is aberrantly regulated by various stimuli in a high proportion of patients with primary aldosteronism[J]. J Clin Endocrinol Metab, 2021, 106(1): e45-e60. doi: 10.1210/clinem/dgaa703 pmid: 33000146

Evolution of understanding of primary bilateral macronodular adrenal hyperplasia

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 21

Related Articles 9

Recommended Articles

Metrics

Comments

[1]	GU Yanyun, ZHOU Weiwei, WANG Weiqing, et al. Primary pigmented nodular adrenocortical disease [J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(04): 230-233.
[2]	WU Luming, WANG Weiqing. Clinical and basic research on adrenal cortical carcinoma [J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(04): 234-238.
[3]	ZHANG Cui, WANG Weiqing. Ectopic adrenocorticotropic hormone syndrome [J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(04): 242-246.
[4]	ZHOU Weiwei, ZHENG Sichang, WANG Weiqing. New understanding of mechanism of Cushing’s disease [J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(04): 247-250.
[5]	JIANG Yiran, WANG Weiqing. Research progress on molecular mechanism of primary aldosteronism [J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(04): 261-265.
[6]	KE Yuya, GONG Yanchun. Research progress of cardiovascular damage in primary aldosteronism [J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(04): 301-304.
[7]	LAI Liqin, GONG Yanchun. Research progress of chronic kidney injury in primary aldosteronism [J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(03): 211-214.
[8]	Chinese Society of Endocrinology. Guidelines for clinical management of adrenal disease novel coronavirus infection [J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(01): 16-17.
[9]	. [J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(03): 205-207.